Is Eli Lilly discontinuing Strattera?
I've been hearing rumors that Eli Lilly may be discontinuing Strattera, their popular ADHD medication. Can you shed some light on this situation? Is Strattera truly being discontinued, and if so, what are the reasons behind this decision? Are there any alternative medications that patients can consider as a replacement? I'm concerned about the potential impact this may have on patients who rely on Strattera for their ADHD management.
Is Eli Lilly good to invest in?
Is Eli Lilly really worth investing in? Their track record in pharmaceutical innovation seems promising, but the market is so volatile these days. Could their drugs potentially face competition from cheaper generics? And what about their financial health? Are they stable enough to weather any economic storms? I'm also curious about their future growth prospects. Are there any upcoming drugs or technologies that could potentially boost their profits? On the flip side, are there any red flags that investors should be aware of? I'd really appreciate some insights into whether Eli Lilly is a solid choice for my portfolio.